Skip to main content
. 2022 Mar 27;190(1):89–101. doi: 10.1002/ajmg.c.31968

TABLE 5.

Ear‐nose‐throat (ENT) involvement in the Volendam cohort

N %
ENT involvement 31 94
Hearing impairment 18 58
Hearing aids 6 19
Rhinosinusitis 27 87
Nasal polyps 4 13
Eardrum perforation 7 23
OM acuta/otorrea 6 19
OM with effusion 13 42
ENT surgery 8 24
Tympanostomy tube 6 75
Adenotomy 1 13
Sinus surgery 1 13
Mastoidectomy 1 13
Nasal therapy 17 55
Decongestant 3 6
Nasal corticosteroids 13 82
Hypertonic NaCl 10 59
Other 1 17